The prescription drug savings company GoodRx has partnered with Sanofi to offer Americans access to Sanofi’s widely prescribed insulin, Lantus, for just $35. This initiative allows patients with a valid prescription to obtain a $35 coupon for Lantus on GoodRx’s website, which can be redeemed at over 70,000 retail pharmacies nationwide, including CVS, Walgreens, and… Continue reading Sanofi to offer insulin product for $35 to all Americans through GoodRx

CVS is discontinuing the sale of certain common cough and cold medicines that contain phenylephrine as the sole active ingredient. This move by CVS follows the unanimous decision by a panel of advisors to the Food and Drug Administration (FDA) that phenylephrine, a nasal decongestant used in various over-the-counter cold and allergy medications, does not… Continue reading CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves

Pfizer will set the list price for a five-day course of its Covid antiviral drug Paxlovid at $1,390 when it transitions to the commercial market later this year. This price, more than double the $529 paid by the federal government for Paxlovid, has raised concerns among doctors, health experts, and patient advocates that it may… Continue reading Pfizer to price Covid drug Paxlovid at $1,390 per course

Toronto, Ontario–(Newsfile Corp. – October 19, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) (“Justera” or the “Company“) is pleased to announce that it has closed its non-brokered private placement offering, as described in its press release of September 29, 2023 pursuant to the listed issuer financing exemption under Part 5A of… Continue reading Justera Health Announces Closing of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

Amazon Pharmacy has announced that eligible customers in College Station, Texas, can now have their prescription medications delivered by drone. Over 500 medications, including treatments for common conditions, will be available for drone delivery, arriving in less than 60 minutes at no additional cost. To be eligible for drone delivery, customers in College Station must… Continue reading Amazon begins delivering medications by drone in Texas

The Food and Drug Administration (FDA) is taking steps to ban the use of formaldehyde as an ingredient in hair relaxers, with a focus on raising awareness of potential harm to Black women who frequently use such products. Formaldehyde is a toxic substance used in various household items, including cosmetics, and can cause irritation and… Continue reading FDA proposes ban on hair relaxers with formaldehyde

This article discusses the increasing use of medications like Ozempic and Wegovy, originally developed to treat type 2 diabetes, for off-label purposes such as weight loss. These drugs contain the active ingredient semaglutide and have been shown to help people lose significant amounts of weight. New clinical trial findings indicate that semaglutide can also reduce… Continue reading Should Insurance Cover Wegovy, Ozempic and Other New Weight-Loss Drugs?

Johnson & Johnsonon Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year guidance as sales in the company’s pharmaceutical and medical devices businesses surged. It marks J&J’s first quarterly results since it completed the separation from its consumer health spinoff Kenvuein August, the company’s biggest shake-up in its 137-year… Continue reading Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition” or the “Company”) announces that it has completed a second closing pursuant to its previously announced private placement of units of the Company. Pursuant to the second closing, the Company issued 1,596,830 units of the Company at a price of US$0.22 per unit for gross proceeds… Continue reading Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering

Pfizer has lowered its full-year earnings and revenue projections, citing decreased demand for its COVID-related products. The company now anticipates 2023 sales in the range of $58 billion to $61 billion, a significant reduction from its previous estimate of $67 billion to $70 billion. This revenue adjustment is primarily attributed to the decline in demand… Continue reading Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump

Rite Aid, a drugstore chain, has filed for Chapter 11 bankruptcy protection in New Jersey as it grapples with declining sales, mounting debt, and legal challenges related to its alleged role in fueling the opioid epidemic. The company is embarking on a restructuring plan that includes evaluating its retail locations and closing underperforming stores. Lenders… Continue reading Rite Aid files for bankruptcy amid slowing sales, opioid litigation

UnitedHealth, a managed-care giant, reported strong financial results, with adjusted earnings of $6.56 per share and revenues of $92.4 billion for the third quarter of the year, surpassing Wall Street expectations. In response, UnitedHealth’s shares increased by approximately 2% to reach around $535 each, contributing to a nearly 1% rise in the S&P 500 healthcare… Continue reading UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says